News

Call for the Defence-related Research Action (DEFRA) is officially open

Published on | 6 months ago

Programmes Security AI Continent Cybersecurity Defence Space

The fifth call for proposals of the Defence-related Research Action (DEFRA) is officially open.

All information is available on the DEFRA website. Pre-proposals can be submitted via the online submission platform. Deadline is Deadline is 20 February 2025, 14h.

We recommend you start preparing your proposal on the online submission platform as soon as possible.

An information day will take place 22 January 2025 at the Royal Military Academy in Brussels. Registration is mandatory. You can register until 15 January 2025.

see also Info day on the DEFRA call 2025  

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1635 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.